IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
62 hedge funds and large institutions have $742M invested in IGM Biosciences in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.42% more ownership
Funds ownership: 50.59% → 55% (+4.4%)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
Holders
62
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$27.2M | |
| 2 | +$15.1M | |
| 3 | +$11.2M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$9.16M |
| 5 |
BlackRock
New York
|
+$6.38M |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$5.57M | |
| 3 | -$3.82M | |
| 4 |
EP
Eversept Partners
New York
|
-$3.08M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.43M |